These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8898988)

  • 1. Studies of oncogene activation and tumor suppressor gene inactivation in normal and neoplastic rodent tissue.
    Buzard GS
    Mutat Res; 1996 Sep; 365(1-3):43-58. PubMed ID: 8898988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
    Stanley LA
    Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice as models for tumorigenesis.
    Merlino G
    Cancer Invest; 1994; 12(2):203-13. PubMed ID: 8131095
    [No Abstract]   [Full Text] [Related]  

  • 6. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia.
    Fowlis DJ; Balmain A
    Eur J Cancer; 1993; 29A(4):638-45. PubMed ID: 8435223
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation patterns in non-ras oncogenes and tumour suppressor genes in experimentally induced tumours.
    Perantoni AO; Rice JM
    IARC Sci Publ; 1999; (146):87-122. PubMed ID: 10353385
    [No Abstract]   [Full Text] [Related]  

  • 8. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene activation in spontaneous and chemically induced rodent tumors: implications for risk analysis.
    Reynolds SH; Stowers SJ; Patterson RM; Maronpot RR; Anderson MW
    Environ Health Perspect; 1988 Jun; 78():175-7. PubMed ID: 3203636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.
    Wogan GN
    Environ Health Perspect; 1992 Nov; 98():167-78. PubMed ID: 1486846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recessive oncogenes.
    Bookstein R; Allred DC
    Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine tumor suppressor models.
    Venkatachalam S; Donehower LA
    Mutat Res; 1998 May; 400(1-2):391-407. PubMed ID: 9685699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do mutated oncogenes and tumor suppressor genes cause cancer?
    Grandér D
    Med Oncol; 1998 Apr; 15(1):20-6. PubMed ID: 9643526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of chemically induced carcinogenesis].
    Palut D; Kostka G; Adamczyk M
    Rocz Panstw Zakl Hig; 1998; 49(1):35-54. PubMed ID: 9734231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topological evidence of differential oncogene activation-tumor suppressor gene inactivation features in 10 human neoplasias, as revealed by sequential regression analysis of world cancer incidence data.
    Kodama M; Murakami M; Kodama T
    Anticancer Res; 1997; 17(5B):3809-16. PubMed ID: 9427785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
    Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular biology of carcinogenesis.
    Pitot HC
    Cancer; 1993 Aug; 72(3 Suppl):962-70. PubMed ID: 8334671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of oncogenes in chemical carcinogenesis.
    Stowers SJ; Maronpot RR; Reynolds SH; Anderson MW
    Environ Health Perspect; 1987 Nov; 75():81-6. PubMed ID: 3319570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncogenes, antioncogenes and carcinogenesis].
    Kopnin BP
    Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.
    Zecchin D; Arena S; Martini M; Sassi F; Pisacane A; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2013 Feb; 34(2):330-7. PubMed ID: 23292961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.